| Mr Thomas Gilman Lang, MD | |
|
741 Sesame St, 1-b, Anchorage, AK 95503-6657 | |
| (907) 561-5801 | |
| (907) 563-1372 |
| Full Name | Mr Thomas Gilman Lang |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 741 Sesame St, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134229495 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 1579 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Thomas Gilman Lang, MD 741 Sesame St, 1-b, Anchorage, AK 95503-6657 Ph: (907) 561-5801 | Mr Thomas Gilman Lang, MD 741 Sesame St, 1-b, Anchorage, AK 95503-6657 Ph: (907) 561-5801 |
News Archive
The Cancer Institute of New Jersey (CINJ) has been awarded renewal of its Comprehensive Cancer Center designation from the National Cancer Institute.
IRIN examines maternal and child health in "conflict-afflicted eastern Myanmar, [where] until recently obstetric care was often crude, unsterile and dangerous for both mother and child, health experts say." To address high rates of maternal and infant mortality in the region, "in 2005 several CBOs, the Center for Public Health and Human Rights at Johns Hopkins University, and the Global Health Access Program launched the Mobile Obstetric Medics (MOM) project - dramatically boosting access to care," IRIN writes.
Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acarbose Tablets, 25 mg, 50 mg and 100 mg, the generic version of Bayer's Precose® Tablets, a treatment to be used with diet and exercise to improve glycemic control in adults with type 2 diabetes.
› Verified 3 days ago
Stacey R Nieder, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 3801 University Lake Dr Ste 301, Anchorage, AK 99508 Phone: 907-929-5888 Fax: 907-929-5882 | |
Jean Colesberry Persons, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 1546 Coffey Lane, Anchorage, AK 99501 Phone: 907-277-4187 | |
Douglas C Smith, MD General Practice Medicare: Medicare Enrolled Practice Location: 2900 Providence Dr, Anchorage, AK 99508 Phone: 907-345-0728 Fax: 907-345-0728 | |
Dr. Jean Milner Eaton, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 8700 E Klatt Rd, Anchorage, AK 99507 Phone: 907-345-3606 | |
Dr. Arthur Dewey Tilgner, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 5011 Spenard Rd, Anchorage, AK 99517 Phone: 907-245-4359 | |
Dr. Ronald E Christensen, MD General Practice Medicare: Medicare Enrolled Practice Location: 9500 Independence Dr, Ste 900, Anchorage, AK 99507 Phone: 907-522-1341 Fax: 907-522-1343 |